School Based Prevention for Childhood Anxiety

Anxiety Disorders Clinical Trial

Official title:

School Based Prevention for Childhood Anxiety

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03044678
• Other study ID #: MH086687
• Status: Completed
• Phase: N/A
• First received: January 30, 2017
• Last updated: February 6, 2017
• Start date: January 1, 2010
• Est. completion date: January 1, 2015

Study information

• Verified date: February 2017
• Source: Arizona State University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study was designed to conceptualize a school-based prevention program or childhood anxiety.

Description:

This is a project corresponding to a career development grant. The main goal of the proposed research was to identify potential barriers to implementing a school-based anxiety preventive intervention, identify strategies to overcome these barriers, and use this information to test a school-based indicated intervention for child anxiety.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 109
• Est. completion date: January 1, 2015
• Est. primary completion date: January 1, 2015
• Accepts healthy volunteers: No
• Gender: All
• Age group: 8 Years to 11 Years

Eligibility

Inclusion:

Borderline child anxiety levels based on the Spence Child Anxiety Scale

Exclusion:

Externalizing problems (based on teacher nominations) more severe than Spence Child Anxiety Scale borderline levels

Related Conditions & MeSH terms

• Anxiety Disorders

Intervention

Behavioral:
• REACH for Success
Exposure-based cognitive behavioral with social skill training (cognitive self control, relaxation, skills for conversations and assertiveness)
• Self-Study
Books for youth about anxiety management

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Arizona State University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in child anxiety symptoms (clinical)	Child anxiety symptoms based on the Multidimensional Anxiety Scale for Children	Change from baseline to 12-month follow-up
Primary	Change in child anxiety levels (typical)	Child anxiety based on the Spence Child Anxiety Scale	Change from baseline to 12-month follow-up
Secondary	Changes in child negative cognition	Children's Negative Cognitive Errors on the Children's Negative Cognitive Errors Questionnaire	Change from baseline to immediate posttest (at 6-weeks)
Secondary	Changes in child negative cognition	Children's Negative Cognitive Errors on the Children's Negative Cognitive Errors Questionnaire	Change from baseline to 12-month follow-up
Secondary	Changes in emotion understanding and expression	Children's Emotion Expressivity based on the Emotion Expressivity Scale for Children	Change from baseline to immediate posttest (at 6-weeks)
Secondary	Changes in emotion understanding and expression	Children's Emotion Expressivity based on the Emotion Expressivity Scale for Children	Change from baseline to 12-month follow-up)
Secondary	Changes in self efficacy	Child self efficacy based on the Children's Self-Efficacy Questionnaire for Handling School Situations	Change from baseline to immediate posttest (at 6-weeks)
Secondary	Changes in self efficacy	Child self efficacy based on the Children's Self-Efficacy Questionnaire for Handling School Situations	Change from baseline to 12-month follow-up)
Secondary	Changes in child social skills	Child social skills based on the Social Skills Improvement Rating System	Change from baseline to immediate posttest (at 6-weeks)
Secondary	Changes in child social skills	Child social skills based on the Social Skills Improvement Rating System	Change from baseline to 12-month follow-up)
Secondary	Changes in somatic arousal	Child somatic arousal based on the Physiological Hyperarousal Scale for Children	Change from baseline to immediate posttest (at 6-weeks)
Secondary	Changes in somatic arousal	Child somatic arousal based on the Physiological Hyperarousal Scale for Children	Change from baseline to 12-month follow-up)